Vivos Therapeutics Inc. (VVOS)
NASDAQ: VVOSHealthcareMedical DevicesUSD
At close: Oct 8, 4:00 PM ET · Delayed 15 min
VVOS stock chart
Technical analysisKey statistics
All statistics- Market cap
- $5.02M
- EPS (TTM)
- -$1.88
- Dividend yield
- None
- 52-week range
- 0.129 – 3.28
- Day range
- 0.146 – 0.1536
- Volume / Avg
- 584.20K / 12.57M
- Beta
- —
- Shares outstanding
- 33.61M
52-week range
VVOS stock today
On Oct 8, VVOS ended the session at $0.1495, shedding $0.0015 (0.99%), versus the S&P 500's 0.47% decline. Trading was light, with 584.20K shares changing hands, about 5% of the average daily volume. At this level, VVOS sits near the bottom of its 52-week range of $0.129 to $3.28: 95.4% below the high and 15.9% above the low.
Vivos Therapeutics has posted a net loss over the last twelve months (EPS of -$1.88), so its P/E ratio is not meaningful.
Summary generated from market data by MetaCap's automated system. Methodology
About Vivos Therapeutics
Company profileVivos Therapeutics, Inc. operates as a medical technology and healthcare services company that develops and commercializes treatment modalities for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults. It offers The Vivos Method, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
- Sector
- Healthcare
- Industry
- Medical Devices
- CEO
- Mr. R. Kirk Huntsman
- Headquarters
- Littleton, CO
- Employees
- 268
- IPO year
- 2020
- Website
- vivos.com
Analyst forecast
ForecastConsensus (3 analysts)
none
Avg. price target
$2.12+1318.06%
- Strong buy 0
- Buy 2
- Hold 1
- Sell 0
- Strong sell 0
Target range
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
Vivos Therapeutics peers
Healthcare sector| Company | Price | % Chg | Market cap | Compare |
|---|---|---|---|---|
| INBSIntelligent Bio Solutions Inc. | 1.57 | -1.26% | $5.21M | vs VVOS |
| TRIBTrinity Biotech plc ADR | 6.04 | -10.91% | $4.91M | vs VVOS |
| ICCMIceCure Medical Ltd. | 1.13 | -1.74% | $5.24M | vs VVOS |
| AIDX20/20 Biolabs Inc. | 0.379 | +10.33% | $4.84M | vs VVOS |
| POASPhaos Technology Holdings (Cayman) Limited Class A | 0.142 | -4.38% | $4.48M | vs VVOS |
| NVNOenVVeno Medical Corporation | 8.18 | -2.68% | $5.68M | vs VVOS |
| AMIXAutonomix Medical Inc. | 3.13 | -8.21% | $6.13M | vs VVOS |
| BJDXBluejay Diagnostics Inc. | 0.8156 | +0.68% | $3.64M | vs VVOS |
Indexes, lists and sector
Appears in lists
Vivos Therapeutics stock FAQ
What is Vivos Therapeutics's stock price today?
VVOS last traded at $0.1495 as of Oct 8, 4:00 PM EDT, down 0.99% on the day. Prices are delayed at least 15 minutes.
Who is Vivos Therapeutics's CEO?
Mr. R. Kirk Huntsman is the chief executive officer of Vivos Therapeutics Inc., which has about 268 employees.
What is the VVOS 52-week high?
The 52-week high for VVOS is $3.28 and the 52-week low is $0.129. The stock is currently 95.4% below its high.